Primary Immunodeficiency Disease News

Patients with atopic dermatitis, especially those with more severe forms of the disease, are at increased risk for multiple autoimmune conditions, according to a study published in The Journal of Allergy and Clinical Immunology.

Warts, hypogammaglobulinemia, infections and myelokathexis — or WHIM — syndrome is a rare but important primary immunodeficiency that leaves some patients susceptible to life-threatening infections as well as to cancer.

Patients with antibody deficiencies demonstrated reduced immunogenicity following vaccination against the SARS-CoV-2 virus, according to a study published in Journal of Clinical Immunology.

Leading specialists in allergy, asthma and immunology have formed Healio Allergy/Asthma’s Peer Perspective Board to help guide coverage and provide their expert take on the latest advances in the field.

Ocular manifestations appeared common among patients with primary immunodeficiency diseases, suggesting a need for more integrated ocular and immunological care, according to a study.

Gene therapy appeared safe and effective for children with Wiskott-Aldrich syndrome without a suitable donor for hematopoietic stem cell transplantation, according to a study published in Nature Medicine.

“Communication problems” that result from defects in types of immune cells including B cells impair immune response and may play a role in common variable immunodeficiency, according to a study published in Nature Communications.

A prototype point-of-care rapid screening device differentiated between low immunoglobulin G antibody levels associated with agammaglobulinemia and normal levels, according to a study published in Journal of Clinical Immunology.

Convalescent plasma appeared safe and effective for the treatment of COVID-19 among patients with primary antibody deficiency, according to a study published in Journal of Clinical Immunology.

The FDA approved immune globulin subcutaneous (human)-hipp, 16.5% solution, or cutaquig, for the treatment of children aged at least 2 years with primary humoral immunodeficiency, according to a press release.